-
Isolation of a transforming sequence from a human bladder carcinoma cell line.
We have isolated the component of human bladder carcinoma cell DNA that is able to transform mouse fibroblasts. The oncogenic sequence was isolated initially from a lambda phage genomic library made from DNA of a transfected mouse cell carrying the human oncogene. A subcloned insert of 6.6 kb that carried transforming activity was amplified in the plasmid vector pBR322. The subcloned oncogene has been used as a sequence probe in Southern blot analyses. The oncogene appears to derive from sequences present in normal cellular DNA. Structural analysis has failed so far to reveal differences between the oncogene and its normal cellular homolog. The oncogene is unrelated to transforming sequences detected in a variety of other types of human tumor cell lines derived from colonic and lung carcinoma and from neuroblastoma. In contrast, the EJ bladder oncogene appears closely related to one that is active in the human T24 bladder carcinoma cell line. The oncogene appears to have undergone little, if any, amplification in several bladder carcinoma cell lines.
PMID: 6286138 [PubMed - indexed for MEDLINE]
-
Cited by over 100 PubMed Central articles
-
Inhibition of PI3K/AKT and MEK/ERK pathways act synergistically to enhance antiangiogenic effects of EGCG through activation of FOXO transcription factor.
Shankar S, Chen Q, Srivastava RK.
J Mol Signal. 2008 Mar 20; 3:7. Epub 2008 Mar 20.
[J Mol Signal. 2008]
-
Tumour prevention by a single antibody domain targeting the interaction of signal transduction proteins with RAS.
Tanaka T, Williams RL, Rabbitts TH.
EMBO J. 2007 Jul 11; 26(13):3250-9. Epub 2007 Jun 14.
[EMBO J. 2007]
-
Reversal of human cellular senescence: roles of the p53 and p16 pathways.
Beauséjour CM, Krtolica A, Galimi F, Narita M, Lowe SW, Yaswen P, Campisi J.
EMBO J. 2003 Aug 15; 22(16):4212-22.
[EMBO J. 2003]
- » See all...